February 2025

Comparing popular TAVR valves | Teleflex to acquire Biotronik assets for $791M | FDA sued over semaglutide | Google's good news ()
Detecting inflammation on CT holds promise | Heart device company to go public | New coronary DCB trial underway ()
FDA announces Class I recall of pacemakers | Johnson & Johnson resumes PFA rollout | LAAO or DOAC? AI can help ()
SCAI recommendations for TAVR access | Cerebral embolic protection | Heart surgery during pregnancy | A new era for Heartflow ()
New drugs target Lp(a) | Nuclear imaging shortage prompts alternative for cardiac amyloidosis | RDN support sent to CMS ()
Class I recall for pacemakers | Open heart surgery performed mid-delivery | AHA supports NIH | Semaglutide shortage ends ()
Week in Review: A new heart pump recall | Embracing the future | Opportunistic imaging | Aspartame linked to new risks ()
Cleerly's founder shares his story | Questioning FDA device approvals | FDA OKs new insulin biosimilar | Getinge makes a shift ()
CABG still the ‘gold standard’ | What sets sotagliflozin apart from other heart drugs | Aspartame & heart health ()
J&J resumes PFA rollout after review | Cardiovascular care for veterans | A potential new therapy for heart disease ()
Heart pumps recalled over safety concerns | LAAO or DOAC? AI can help | Detecting signs of heart disease in cancer images ()
Week in Review: FDA's new safety warning | J&J considering a sale | AVR recommended for asymptomatic severe AS | Much more ()
AVR recommended for asymptomatic severe AS | The most lucrative heart procedures | HeartBeam's public offering ()
Final decision on new cardiovascular board coming soon | J&J may sell its stroke business | Biolimus-coated balloons fall short ()
Interventional heart failure: A subspecialty on the rise | ACC takes on key policy issues | Novartis to acquire drugmaker ()
Benzodiazepine use before heart surgery: Should it be embraced or restricted? | Beta-blockers & takotsubo syndrome ()
FDA's warning about atherectomy devices | New ASE guidelines | AI boosts stroke care | Heart patient's family settles lawsuit ()
Week in Review: Be good to your teeth | TAVR on the weekend | Cardiologist-supported bill returns to Congress | More ()
Follow-up care worse for women | COVID-19 linked to plaque growth, long-term cardiovascular risks | THT 2025 ()
FDA's new medical device warning | Cardiologist & clinic settle whistleblower lawsuit | Home-based rehab ()
What many people get wrong about aspirin | Flossing reduces cardiovascular risks | Long-term success with the Ross procedure ()
January's Top Stories: Safety concerns lead to 3 major recalls | J&J puts PFA on hold | The best diets for heart health ()
TAVR on the weekend vs. weekdays | ICE & structural heart procedures | AI takes NLP to the next level | The consequences of PAD ()
Bill to stop Medicare cuts returns to Congress | PCI before TAVR vs. both at once | Progress for new TAH tech ()
Week in Review: BP drug recalled | Bad diet leads to cholesterol on patient's hands | FDA clears first blood test of its kind ()